• Home
  • Dermatologic immune-related adverse events to checkpoint inhibitors in cancer.

Dermatologic immune-related adverse events to checkpoint inhibitors in cancer.

Author List
Shah NJ, Lacouture ME
Publication
The Journal of allergy and clinical immunology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/366110478
Publication Year
2022
PubMed ID
36463979
Publication Title
Shah NJ, Lacouture ME. Dermatologic immune-related adverse events to checkpoint inhibitors in cancer. J Allergy Clin Immunol. 2023 02; 151(2):407-409.